These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 21251242

  • 1. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity.
    Moseng L, Sæter M, Mørch-Johnsen GH, Hoff JM, Gajda A, Brodtkorb E, Midelfart A.
    Acta Ophthalmol; 2011 Aug; 89(5):452-8. PubMed ID: 21251242
    [Abstract] [Full Text] [Related]

  • 2. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity.
    Lawthom C, Smith PE, Wild JM.
    Ophthalmology; 2009 Mar; 116(3):565-71. PubMed ID: 19168223
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss--could scanning laser polarimetry aid diagnosis?
    Durnian JM, Clearkin LG.
    Eye (Lond); 2008 Apr; 22(4):559-63. PubMed ID: 17401319
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vigabatrin-attributable visual field defects in patients with intractable partial epilepsy.
    Tseng YL, Lan MY, Lai SL, Huang FC, Tsai JJ.
    Acta Neurol Taiwan; 2006 Dec; 15(4):244-50. PubMed ID: 17214087
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glaucoma detection by Stratus OCT.
    Hougaard JL, Heijl A, Bengtsson B.
    J Glaucoma; 2007 May; 16(3):302-6. PubMed ID: 17438424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vigabatrin-associated visual field defects in children.
    Russell-Eggitt IM, Mackey DA, Taylor DS, Timms C, Walker JW.
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():334-9. PubMed ID: 11026995
    [Abstract] [Full Text] [Related]

  • 16. Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures.
    Sergott RC, Johnson CA, Laxer KD, Wechsler RT, Cherny K, Whittle J, Feng G, Lee D, Isojarvi J.
    Epilepsia; 2016 Oct; 57(10):1634-1642. PubMed ID: 27580566
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In utero exposure to vigabatrin: no indication of visual field loss.
    Lawthom C, Smith PE, Wild JM.
    Epilepsia; 2009 Feb; 50(2):318-21. PubMed ID: 18616557
    [Abstract] [Full Text] [Related]

  • 20. The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin.
    Wild JM, Aljarudi S, Smith PEM, Knupp C.
    CNS Drugs; 2019 Feb; 33(2):161-173. PubMed ID: 30637668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.